ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1980

Movement Evoked Pain as an Outcome Measure in Patients with Knee Osteoarthritis

Leila Bagherzadeh1, Schnitzer Thomas2, Santiago Espinosa-Salas1 and Joana Barroso3, 1Northwestern Physical Medicine and Rehabilitation Department, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Anesthesiology; Feinberg School of Medicine, Chicago, IL

Meeting: ACR Convergence 2023

Keywords: Osteoarthritis, Outcome measures, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1977–1995) Osteoarthritis – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Pain, being one of the most crucial symptoms associated with knee OA, serves as a significant outcome measure for the increasing number of studies focusing on pain management strategies. Many people with OA have no or minimal pain at rest. Therefore, identifying procedures to evoke the pain associated with OA would be of value in evaluating both neurosensory pathways important for pain perception as well as possible acute interventions focused on relieving pain. We believe there is potential clinical value in differentiating and measuring pain during physical activity as a separate construct from pain at rest. In this study, we aimed to evaluate a novel method for inducing knee pain using a stair-stepper machine.

Methods: This study was part of a randomized, double-blind, cross-over trial to evaluate the efficacy of a topical treatment for patients with knee OA (NCT01654302). In this trial, 40 patients were assessed in 2 visits at least one week apart. In each visit, two exercise sessions were conducted, one before treatment and one after treatment. In this abstract, we focus on the findings of the first exercise session. After providing consent, patients reported their baseline pain level using a Numerical Rating Scale (NRS) from 0 to 10, with 0 meaning no pain and 10 meaning worst imaginable pain. Patients were instructed to use a commercially available stair-stepper machine (STAMINA, Springfield, MO) for a maximum of 2 minutes or until they reached maximum bearable pain. After completion of the exercise, participants assessed their knee pain intensity at 1, 5, and 60 minutes after stopping. The primary outcome measure was a change in pain intensity after exercise. To evaluate if exercise caused a significant increase in pain, we conducted a repeated measures ANOVA model to compare the NRS levels before exercise with those at 1 minute, 5 minutes, and 60 minutes after stopping exercise for two visits. Subsequently, we performed pairwise comparisons using Tukey’s Honestly Significant Difference (HSD) test to further examine specific differences between the time points.

Results: Participants included 24 females and 16 males with an average age of 58 ± 7.7 years; The average pain level is presented in Table 1 and Figure 1. The analysis revealed a significant effect (F(3,df) = 31.52, p< 0.001) for visit 1 and (F(3,df) = 3.95, p< 0.01) for visit 2, indicating differences among time points for both visits. Further analysis of multiple comparisons for visit 1 showed a statistically significant increase in NRS after 1, 5, and 60 minutes compared to the baseline. However, for visit 2, the only significant difference was observed for 1 minute compared to 60 minutes. This finding could potentially be attributed to the patients’ prior experience with the exercise method.

Conclusion: The ability to reliably and reproducibly generate movement-evoked pain in patients with knee OA holds promise for assessing acute treatment interventions as well as evaluating neurosensory pathways, e.g., brain MRI which can help define the basis for pain perception in OA. Further studies with larger sample sizes are warranted to validate this approach and assess its sensitivity to treatment-induced pain changes.

Supporting image 1

Table 1. Pain NRS scores for visit 1 and visit 2

Supporting image 2


Disclosures: L. Bagherzadeh: None; S. Thomas: AstraZenica, 2, Eli Lilly, 2, GlaxoSmithKline, 2, Horizon, 2, IBSA Group, 2, Merck, 2, Moebius Medical, 2, Orion, 2, Paradigm Biopharmaceuticals, 5, Pfizer, 1, 2, Regeneron, 2, Xalud Therapeutics, 2; S. Espinosa-Salas: None; J. Barroso: None.

To cite this abstract in AMA style:

Bagherzadeh L, Thomas S, Espinosa-Salas S, Barroso J. Movement Evoked Pain as an Outcome Measure in Patients with Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/movement-evoked-pain-as-an-outcome-measure-in-patients-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/movement-evoked-pain-as-an-outcome-measure-in-patients-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology